$1.5M SBIR Phase II Grant Awarded to Expand Ligo-miR Technology
Circulomics issues a press release to announce a $1.5M Phase II SBIR award given by the National Institutes of Health (NIH) - National Institute of General Medical Sciences (NIGMS) to further develop the Ligo-miR microRNA assay platform. This award follows a previous $400k Phase I award and will create a comprehensive portfolio of Ligo-miR products designed to address broad swaths of the microRNA market. Ligo-miR offers customers an unrivaled combination of sensitivity, sample throughput, and low cost by using a novel multiplex technology to perform targeted profiling of 10-100 microRNA in a single reaction.
Circulomics receives coverage on GenomeWeb.